We are live on ! Find out more
LSBPW

LakeShore Biopharma Warrants
LSBPW

Delisted

LSBPW was delisted on the 19th of September, 2025.

Back to rankings

1 hedge funds and large institutions have $3 invested in LakeShore Biopharma Warrants in 2026 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% less funds holding

Funds holding: 2 → 1 (-1)

83% less capital invested

Capital invested by funds: $18 → $3 (-$15)

Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

LSBPW Hedge Fund Activity: Q2 2026 in Review

1 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in LakeShore Biopharma Warrants (LSBPW) for Q2 2026, worth a combined $3 — down 83% from $18 a quarter earlier.

Fund positioning in LSBPW was balanced in Q2 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held LakeShore Biopharma Warrants (LSBPW) as of Q2 2026, down from 2 in Q1 2026.
  • Funds reported $3 of LakeShore Biopharma Warrants stock for Q2 2026, down 83% quarter-over-quarter.
  • 0 funds opened new LakeShore Biopharma Warrants positions in Q2 2026 and 0 closed out.

Based on aggregated 13F filings for Q2 2026.